Thomas J. Lynch Jr., MD

/content/dam/www/leadership-photos/thomas-lynch/thomas-lynch.jpg
Dr. Thomas J. Lynch Jr. MD
Faculty Member

Thomas J. Lynch Jr., MD

President and Director, Fred Hutch

President and Director
Fred Hutch

Raisbeck Endowed Chair for the President and Director, Fred Hutch

Raisbeck Endowed Chair for the President and Director
Fred Hutch

Fax: 206.667.5268
Mail Stop: D1-060

Dr. Thomas J. Lynch Jr. is a world-renowned scientist, highly respected oncologist and successful leader of National Cancer Institute-Designated Comprehensive Cancer Centers . As president and director of Fred Hutchinson Cancer Center, Dr. Lynch sets the strategic direction of the center, oversees centerwide initiatives and represents Fred Hutch’s interests to major partners and governmental bodies. He also directs the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and is principal investigator of its Cancer Center Support Grant. Before taking over as Fred Hutch’s sixth president in February 2020, Dr. Lynch was most recently chief scientific officer of Bristol-Myers Squibb. Prior to that he held leadership roles as CEO of Massachusetts General Physicians Organization, director of Yale Cancer Center, physician-in-chief at Yale’s Smilow Cancer Hospital, chief of hematology-oncology at Massachusetts General Hospital and professor of medicine at Harvard Medical School. Dr. Lynch is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer. Earlier in his career he was part of the first research team to discover how targeted therapies could dramatically change outcomes for lung cancer patients with mutations in the EGFR, or epidermal growth factor receptor, gene.

Media

Saving a city: How Seattle’s corporate giants banded together to flatten the curve (Fortune)

Other Appointments & Affiliations

Chairman, Finance Committee
American Association for Cancer Research

Member
American Society of Clinical Oncology

Member
International Association for the Study of Lung Cancer

Education

Yale University, 1986, MD

Yale College, 1982, BS (Biology, magna cum laude)

Honors and Awards

1983 Research Prize, National Medical Student Research Forum
1986 Nicholas Giarman Prize in Pharmacology, Yale Medical School
1989-1990 American Cancer Society Clinical Fellow, Dana-Farber Cancer Institute
1998 Teaching Award from First Year Oncology Fellows, Massachusetts General Hospital/Dana-Farber Cancer Institute  
2009 Award for Scientific Excellence, International Association for the Study of Lung Cancer
2009 Joseph Martin Prize for Research, Massachusetts General Hospital
2010 Team Science Award, American Association for Cancer Research